BioSig Technologies Inc's Vice President of Clinical Affairs Julie Stephenson tells Proactive that clinical data acquired by its PURE EP System has been published in the Journal of Cardiovascular Electrophysiology.
Stephenson says the PURE EP 2.0 study was conducted at three US hospitals - Texas Cardiac Arrhythmia Institute at St. David’s Medical Center, Mayo Clinic Jacksonville, and Massachusetts General Hospital. BioSig said the results showed 93% consensus across the blinded reviewers with a 75% overall improvement in intracardiac signal quality and confidence in interpreting PURE EP signals over the signals from conventional sources.